Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Gutierrez

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|November 27, 2002
[Gemicitabine in the treatment of epithelial ovarian cancer]Patricia Pautier, Maya Gutierrez, Catherine Lhomme
Gynecologic Oncology Case Reports|December 28, 2013
Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literatureHanane Inrhaoun, Ibrahim Elghissassi, Maya Gutierrez, et al.
Revue De L'Infirmiere|April 4, 2018
[Smart health, care relationship and ethics]Maya Gutierrez, Carla Matta, Léontine Miret, et al.
Bulletin Du Cancer|May 5, 2011
[Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?]Maya Gutierrez, Souad Lyazidi, Louis Brasseur, et al.
British Journal of Clinical Pharmacology|February 26, 2008
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized studyEtienne G C Brain, Kevan Rezai, François Lokiec, et al.
Bulletin Du Cancer|May 5, 2011
[Brain metastases from breast cancer: usefulness and limits of prognostic scores]Romuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Bulletin Du Cancer|December 17, 2008
[Breast cancer in the elderly]Maya Gutierrez, Fatma Ben Abid, Amale Ousbane, et al.
Cancers|April 26, 2019
Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac MusclesJoshua R Huot, Alyson L Essex, Maya Gutierrez, et al.
BMC Cancer|September 21, 2011
Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of deathRomuald Le Scodan, Ludivine Jouanneau, Christophe Massard, et al.
Journal of Neuro-Oncology|July 8, 2011
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatmentRomuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|November 27, 2002
[Gemicitabine in the treatment of epithelial ovarian cancer]Patricia Pautier, Maya Gutierrez, Catherine Lhomme
Gynecologic Oncology Case Reports|December 28, 2013
Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literatureHanane Inrhaoun, Ibrahim Elghissassi, Maya Gutierrez, et al.
Revue De L'Infirmiere|April 4, 2018
[Smart health, care relationship and ethics]Maya Gutierrez, Carla Matta, Léontine Miret, et al.
Bulletin Du Cancer|May 5, 2011
[Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?]Maya Gutierrez, Souad Lyazidi, Louis Brasseur, et al.
British Journal of Clinical Pharmacology|February 26, 2008
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized studyEtienne G C Brain, Kevan Rezai, François Lokiec, et al.
Bulletin Du Cancer|May 5, 2011
[Brain metastases from breast cancer: usefulness and limits of prognostic scores]Romuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Bulletin Du Cancer|December 17, 2008
[Breast cancer in the elderly]Maya Gutierrez, Fatma Ben Abid, Amale Ousbane, et al.
Cancers|April 26, 2019
Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac MusclesJoshua R Huot, Alyson L Essex, Maya Gutierrez, et al.
BMC Cancer|September 21, 2011
Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of deathRomuald Le Scodan, Ludivine Jouanneau, Christophe Massard, et al.
Journal of Neuro-Oncology|July 8, 2011
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatmentRomuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Pageof 2